Medical News | Skin Cancer

Editor's Choice

New Laser-Based Tool Accurately Identifies Melanoma

A new laser-based tool may help physicians better diagnose melanoma, according to research published in the Feb. 23 issue of Science Translational Medicine.

LATEST ARTICLES

New sunscreen labeling represents step forward in improving photoprotection

Implementation of the final regulations from the Food and Drug Administration for sunscreen testing and labeling should enable consumer selection of effective sunscreen products. More work is still needed, however, to better educate the public about the damaging effects of UV exposure and to motivate appropriate sunscreen use, says Vincent A. DeLeo, M.D.

Actinic keratosis, NMSC treatments benefit from innovative approaches

Future management of actinic keratosis (AK) and nonmelanoma skin cancer (NMSC) will involve creative uses of conventional therapies, particularly in multimodal regimens, and it will be expanded by recent advances in chemotherapy, according to Theodore Rosen, M.D., who spoke at the 30th annual Fall Clinical Dermatology Conference.

Lymphoma diagnosis may be missed without careful evaluation, multiple biopsies

The cutaneous symptoms of lymphoma and atopic dermatitis (AD) can mimic one another, particularly when AD is severe. An accurate evaluation and assessment of the presenting clinical symptoms is crucial in avoiding a potential misdiagnosis of either disease.

Photodynamic therapy increasingly valuable with ongoing experience

Accumulating experience with photodynamic therapy (PDT) has led to an expanding list of applications and new protocols that together have made PDT an increasingly valuable tool in the management of actinic keratosis (AK) and nonmelanoma skin cancer (NMSC).

Epidemiology data for melanoma serves up good, bad news

Although dermatologists may be disheartened by the latest melanoma epidemiology data showing continued rises in incidence and the annual number of melanoma-related deaths, recent advances in prevention, diagnosis and treatment should raise hope for the future, according to Darrell S. Rigel, M.D., who spoke at the 30th Annual Fall Clinical Dermatology Conference.